Valuation : Rapid Micro Biosystems, Inc.

Market Cap 60.19M 51.76M 48.84M 44.49M 83.18M 5.75B 83.93M 582M 224M 2.92B 226M 221M 9.27B P/E 2026 *
-1.28x
P/E 2027 * -1.65x
Enterprise Value 60.19M 51.76M 48.84M 44.49M 83.18M 5.75B 83.93M 582M 224M 2.92B 226M 221M 9.27B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.29x
Free-Float
81.07%
Yield 2026 *
-
Yield 2027 * -
1 day-0.83%
1 week-13.04%
Current month-21.05%
1 month-29.82%
3 months-34.43%
6 months-70.94%
Current year-58.62%
1 week 1.16
Extreme 1.16
1.38
1 month 1.16
Extreme 1.16
1.77
Current year 1.16
Extreme 1.16
4.94
1 year 1.16
Extreme 1.16
4.94
3 years 0.58
Extreme 0.58
4.94
5 years 0.58
Extreme 0.58
22.71
10 years 0.58
Extreme 0.58
27.04
Manager TitleAgeSince
Chief Executive Officer 57 01/10/2014
Director of Finance/CFO 56 01/10/2018
Chief Tech/Sci/R&D Officer - 01/05/2025
Director TitleAgeSince
Director/Board Member 56 01/10/2018
Director/Board Member 57 01/10/2014
Director/Board Member 77 15/03/2016
Date Insider Type Main position Quantity % Market Cap. Importance
24/07/26 Exercice

Director

7,016 0.0155%
22/07/26 Exercice

Chief Executive Officer

2,804 0.0062%
29/05/26 Free

Director

38,361 0.0921%
Change 5-day change 1-year change 3-year change Capi.($)
-0.83%-13.04%-60.13%+26.32% 60.19M
-0.41%-2.47%+26.57%+16.38% 223B
-2.11%-4.98%+4.12%-19.26% 141B
+2.04%-2.53%-19.89%+20.87% 127B
-4.14%-8.20%-59.04%-19.99% 62.46B
+0.69%-0.82%-19.42%-14.54% 49.73B
+0.68%-3.35%+10.85%+17.15% 50.01B
-1.13%-4.57%+15.31%+25.55% 40.35B
-0.78%-2.88%+37.06%+52.38% 39.46B
-0.17%-4.19%-18.82%+48.42% 31.41B
Average -0.28%-4.64%-8.34%+15.33% 76.48B
Weighted average by Cap. -0.38%-3.34%+1.76%+9.29%

Financials

2026 *2027 *
Net sales 39.32M 33.82M 31.91M 29.07M 54.34M 3.76B 54.83M 380M 146M 1.91B 148M 144M 6.06B 46.5M 39.99M 37.73M 34.37M 64.26M 4.45B 64.84M 449M 173M 2.25B 175M 171M 7.16B
Net income -44.53M -38.3M -36.14M -32.92M -61.54M -4.26B -62.1M -430M -166M -2.16B -167M -164M -6.86B -35.83M -30.82M -29.08M -26.49M -49.52M -3.43B -49.97M -346M -133M -1.74B -135M -132M -5.52B
Net Debt - -
Logo Rapid Micro Biosystems, Inc.
Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission-critical automation solutions to facilitate the manufacturing and release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. Its flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Employees
171
Date Price Change Volume
10/09/26 $1.200 -0.83% 385,165
09/09/26 $1.210 -0.82% 409,335
08/09/26 $1.220 -6.87% 312,439
04/09/26 $1.310 -5.07% 378,832
03/09/26 $1.380 -0.72% 107,263
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.200USD
Average target price
6.667USD
Spread / Average Target
+455.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RPID Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!